Wei-Dong Wei
Overview
Explore the profile of Wei-Dong Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xiao X, Tang H, Xie X, Li L, Kong Y, Wu M, et al.
Asian Pac J Cancer Prev
. 2013 Nov;
14(9):5219-23.
PMID: 24175804
The number of axillary lymph nodes involved and retrieved are important prognostic factors in breast cancer. The purpose of our study was to investigate whether the lymph node ratio (LNR)...
12.
Li X, Feng Y, Wei W, Liu P, Xie Z, Wang J, et al.
World J Surg Oncol
. 2013 Aug;
11(1):183.
PMID: 23938020
Signet-ring cell carcinoma (SRCC) can arise from virtually all organs. However, primary SRCC of the breast is very rare. Until 2003, SRCC was placed under 'mucin-producing carcinomas' and separated from...
13.
Wu M, Hu P, Gao J, Wei W, Xiao X, Tang H, et al.
Asian Pac J Cancer Prev
. 2013 Mar;
14(1):287-92.
PMID: 23534739
Background: Low tyrosine-protein phosphatase nonreceptor type 12 (PTPN12) expression may be associated with breast cancer growth, proliferation, and metastasis. However, the prognostic value of PTPN12 in breast cancer has not...
14.
Ge Q, Lv N, Kong Y, Xie X, He N, Xie X, et al.
Asian Pac J Cancer Prev
. 2012 Dec;
13(10):5081-6.
PMID: 23244114
Background: The liver is one of the most common metastatic sites of breast cancer, hepatic metastases developing in 6%-25% of patients with breast cancer and being associated with a poor...
15.
Chen L, Liang Y, Yang Q, Xu F, Zhou N, Xu G, et al.
Asian Pac J Cancer Prev
. 2012 Aug;
13(5):1863-7.
PMID: 22901137
Background: Maintenance chemotherapy is one strategy pursued in recent years with intent to break through the chemotherapy plateau for advanced non-small cell lung cancer (NSCLC). However, given the toxicity, platinum-based...
16.
Ge Q, Lv N, Cao Y, Wang X, Tang J, Xie Z, et al.
Chin J Cancer
. 2012 Apr;
31(7):354-8.
PMID: 22516480
Primary small cell carcinoma (SCC) of the breast, an exceedingly rare and aggressive tumor, is often characterized by rapid progression and poor prognosis. We report a case of primary SCC...
17.
Chen L, Huang H, Liao H, Liu G, Zeng Y, Dinglin X, et al.
Med Oncol
. 2011 Aug;
29(3):1687-92.
PMID: 21853344
To study the treatment outcomes of brain-only metastases from small-cell lung cancer (SCLC) at initial diagnose treated by chemotherapy with concurrent brain and thoracic radiotherapy (RT). From Jan 2004 to...
18.
Wei W, Fu J, Lin P, Li X, Yang H, Rong T, et al.
Zhonghua Zhong Liu Za Zhi
. 2009 Jan;
30(9):672-5.
PMID: 19173908
Objective: A bias may be produced when only TNM stage is used to predict the prognosis of non-small cell lung cancer (NSCLC) after complete resection and multidisciplinary treatment. The reason...
19.
Wei W, Wen Z, Su X, Lin P, Rong T, Chen L
Ai Zheng
. 2007 Nov;
26(11):1231-6.
PMID: 17991324
Background & Objective: Multi-disciplinary management for non-small cell lung cancer (NSCLC) has been applied for more than ten years. The progresses in the diagnosis and management of NSCLC might change...
20.
Wen Z, Chen X, Wu H, Wei W, Rong T
Ai Zheng
. 2007 Apr;
26(4):415-7.
PMID: 17430664
Background & Objective: No more survival improvement could be obtained in advanced non-small cell lung cancer (NSCLC) today with chemotherapy or radiotherapy. Clinical trails showed the antitumor effect of gefitinib...